My Community
Welcome,
Guest
. Please
login
or
register
.
1 Hour
1 Day
1 Week
1 Month
Forever
Login with username, password and session length
News:
SMF - Just Installed!
Home
Help
Search
Login
Register
My Community
»
Profile of pepperlatex6
»
Summary
Profile Info
Summary
Show Stats
Show Posts...
Messages
Topics
Attachments
Summary
pepperlatex6
Newbie
Offline
Show Posts
Show Stats
Posts:
0 (N/A per day)
Age:
N/A
Date Registered:
December 21, 2024, 02:49:41 PM
Local Time:
December 22, 2024, 07:57:59 AM
Last Active:
December 21, 2024, 04:16:19 PM
Signature:
Neratinib combined with everolimus or trametinib led to a 100% increase in median event-free survival (EFS; tumor doubling time) in 25% (1/4) and 60%